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abstract: A number of case–control studies investigated the association between idiopathic recurrent spontaneous abortion (IRSA) and
variations in the gene encoding endothelial nitric oxide synthase (NOS3), but yielded contradictory results. Our aimwas to test the association of
theNOS3 variable number of tandem repeats (VNTR) in intron 4 and +894 G/T single-nucleotide polymorphism (SNP) with IRSA in Slovenian
women (148 IRSAand149controlwomen), conduct a systematic reviewof literatureon the associationbetweenNOS3 gene variations and IRSA,
and perform meta-analyses of studies that met the inclusion criteria, deﬁned by virtue of the European Society for Human Reproduction and
Embryology evidence-based guidelines for recurrent spontaneous abortion. Genotyping was performed using PCR and restriction fragment
length polymorphism methods. The systematic review of literature (English language) was conducted using PubMed and Scopus databases, to
1 November 2014. We determined no association of IRSAwith the VNTR in intron 4 and +894 G/T SNP in Slovenian women. Furthermore,
16 case–control studies were identiﬁed on the association between 15 NOS3 gene variations and IRSA. However, signiﬁcant inconsistencies
exist in the selection criteria of patients and controls between studies. The meta-analysis of VNTR in intron 4 was performed on ﬁve studies
(894 patients, 944 controls), whereas the meta-analysis of +894 G/T SNP included six studies (1111 patients, 1121 controls). The association
with IRSAwas signiﬁcant for the+894G/TSNPunder the dominant geneticmodel (GT+TTversusGG) basedonﬁxed (odds ratio (OR) ¼ 1.54,
95% conﬁdence interval (CI) ¼ 1.28–1.86, P ¼ ,0.01) and random effectsmodels (OR ¼ 1.54, 95%CI ¼ 1.03–2.31, P ¼ 0.03). In conclusion,
theGT and TT genotypes of the+894G/T SNP inwomenmight contribute to a predisposition to IRSA. Additional genetic association and func-
tional studies in different populations with larger numbers of participants and a uniformly deﬁned IRSA are needed to clarify the contribution of
NOS3 +894 G/T gene variation to IRSA.
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Introduction
Recurrent spontaneous abortion (RSA) is a reproductive disorder that
has been variously deﬁned in the scientiﬁc literature. However, accord-
ing to the European Society for Human Reproduction and Embryology
(ESHRE) evidence-based guidelines for the clinical evaluation and
medical treatment of RSA, the condition is deﬁned as three or more
consecutive spontaneous abortions (SAs) before the 20th week of ges-
tation (the upper limit of gestational week for SA might vary according
to state laws) (Jauniaux et al., 2006). These guidelines are based on data
of RCTs andmeta-analyses, and recommend the basic investigations of
a couple with RSA to include personal, obstetric and family history, ex-
posure to toxins, full blood count, antiphospholipid antibodies, parental
karyotype and pelvic ultrasound and/or hysterosalpingogram. The eti-
ology of RSA is unknown in 50% of couples and is referred to as idio-
pathic RSA (IRSA) (Porter and Scott, 2005; Jauniaux et al., 2006).
Genetic predisposition was proposed as a contributing factor and a
large number of gene variations were tested in women with IRSA
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(Rull et al., 2012). Considering that almost 90% of IRSA occurs before
the 12th week of gestation (Porter and Scott, 2005), the frequently
studied candidate genes are those involved in angiogenesis and vascular
function.
Fetoplacental blood vessels lack autonomic innervation; therefore the
regulation of vascular functions at the fetomaternal interface is mediated
by endothelial cell-derived vasoactive mediators (Toda et al., 2013).
Among these is the endothelial nitric oxide synthase (eNOS), one of
the three isoforms of NOS, which are involved in the production of
nitric oxide (NO). The eNOS is synthesized in endothelial cells and
other cell types, including those of the endometrium and placenta. In
the endometrium, its expression is cyclic with highest levels during the
window of implantation and continues during pregnancy, suggesting a
role in endometrial perfusion, receptivity, implantation and placental
function (Sladek et al., 1997; Khorram et al., 1999; Najaﬁ et al., 2012).
Physiological functions of eNOS-derivedNOarevasodilation and activa-
tion of endothelial progenitor cells, as well as the inhibition of platelet
aggregation, inﬂammation and vascular smooth muscle proliferation
(Fo¨rstermann and Sessa, 2012).
Alterations in eNOS and NO activity were detected in plasma, plate-
lets and endometrium of women with IRSA compared with control
women (Raffaelli et al., 2010; Najaﬁ et al., 2012; Banerjee et al., 2013;
Makino et al., 2004). Considering the altered levels of eNOS and NO
in IRSA women, as well as the importance of eNOS and NO in
angiogenesis, control of vascular tone and anti-thrombotic actions in
endometrium during (pre)decidualisation and in placenta during early
pregnancy, variation in the gene encoding for eNOS (NOS3) has been
proposed as a potential factor of predisposition for IRSA. Association
of IRSA was tested in several studies, which yielded contradictory
results. Furthermore, two meta-analyses assessed whether variable
number of tandem repeats (VNTR) in intron 4 and+894G/T single nu-
cleotide polymorphism (SNP; rs1799983) contribute to IRSA (Su et al.,
2011; Cao et al., 2014).
The present study had three aims. The ﬁrst was to test the association
of NOS3 VNTR in intron 4 and +894 G/T SNP with IRSA in Slovenian
women in a case–control study. The second aim was to conduct a
systematic review of literature on the association between NOS3 gene
variations and IRSA. Finally, we aimed to perform meta-analyses only
of those studies that met the strict inclusion criteria that we deﬁned by
virtue of ESHRE evidence-based guidelines for the evaluation of IRSA
patients (Jauniaux et al., 2006). Therefore, in the work presented
herein, we integrate the results of our own and previously published
studies, but also point out differences between publications on IRSA
regarding the selection criteria of patients and controls.
Methods
Case–control study
Subjects
A case–control study was performed to examine the association of NOS3
VNTR in intron 4 and +894 G/T SNP with IRSA in Slovenian women. All
women were recruited through the Institute of Medical Genetics, Depart-
ment of Obstetrics and Gynaecology, UMC Ljubljana, Slovenia. Written
informed consent for participation in this study was obtained from all parti-
cipants. The study was approved by Slovenian and CroatianNational Ethics’
Committees. The IRSA group consisted of 148 women with a history of
three or more consecutive SAs of unknown etiology before 22nd week of
gestation (91.9% in the ﬁrst 12 weeks and 8.1% between Weeks 13 and
22), with a mean age of 33 years (range 23–46). Exclusion criteria were:
endocrine or metabolic disorders (including diabetes mellitus), antipho-
spholipid syndrome (APS), autoimmune disease or other systemic diseases,
previous venous or arterial thrombosis or uterine anatomical abnormalities
detected by ultrasonography and/or hysteroscopy. All couples had normal
karyotypes. A total of 97 (65.5%) women had no live births (primary IRSA),
whereas 51 (34.5%) women had at least one live born child (secondary
IRSA). Three SAs were present in 136 (91.9%) women and 4–10 SAs in
12 (8.1%) women. The control group consisted of 149 unrelated, healthy
women with at least two live births, and no history of SA or any other preg-
nancy complication.
DNA extraction and molecular analysis
Genomic DNA was isolated from peripheral blood leukocytes by standard
procedures using commercially available kit (Qiagen_FlexiGene kit;
QIAGENGmbH, HildenGermany) as described by the manufacturer. Geno-
typing of VNTR in intron 4 was performed by allele-speciﬁc oligonucleotide
PCR (ASO-PCR) using the following primers: 5′- AGGCCCTATGGTA
GTGCCTTT-3′ and 5′- TCTCTTAGTGCTGTGGTCAC-3′. The wild-type
allele (B) generated a 420 base pair band, whereas the mutant allele (A) gen-
erated a 393 base pair band. Genotyping of +894 G/T SNP was performed
using PCR and restriction fragment length polymorphism (RFLP) methods.
The following primers were used for PCR ampliﬁcation: 5′- CATGAGGC
TCAGCCCCAGAAC-3′ and 5′- AGTCAATCCCTTTGGTGCTCAC-3′,
and yielded a 206 base pair long PCR product. PCR products were digested
with the restriction enzyme MboI (New England Biolabs, Ipswich, MA, USA)
at 378C for 15–20 min. In the presence of the variant allele (T), the product
was cleaved into two fragments of 119 and 87 base pairs. All PCRs were
carried out in thermal cyclers (Mastercycler personal, Eppendorf, Hamburg,
Germany and 2720 Thermal Cycler, Applied Biosystems, Carlsbad, CA,
USA). The PCR and RFLP products were visualized under ultraviolet light
after electrophoresis on 1 and 3% agarose gels, respectively, stained with
GelRedTM (Olerup SSPw, Saltsjo¨baden, Sweden).
Systematic review andmeta-analyses
Search strategy
The systematic reviewof literaturewas conducted using PubMed and Scopus
electronic databases, which were searched for publications on the associ-
ationbetweenNOS3 gene variations and IRSAup to1November 2014.Con-
sidering that the exclusion of non-English language studies changes the effect
estimates less than5% (Ju¨ni et al., 2002),we applied a language restriction and
only reports in the English language were taken into consideration. The
following key words were used: recurrent miscarriage, recurrent pregnancy
loss, recurrent spontaneous abortion or habitual abortion in combination with
endothelial nitric oxide synthase, eNOS or NOS3. In addition, we searched
references of retrieved articles. The search for publications was performed
independently by two authors (N.P., S.O.) and all retrieved articles were
compared to avoid duplication. Any disagreements were discussed and
resolved with consensus.
Study selection
All of the case–control studies in the English language analyzing the associ-
ation between NOS3 gene variations and IRSAwere included in the system-
atic review. However, meta-analyses were performed only for those gene
variations that were tested in at least ﬁve studies that met the following
strict inclusion criteria: (i) case–control study in which genotyping was per-
formed in women with IRSA and control women; (ii) RSA deﬁned as three
or more SAs; (iii) diagnosis of IRSA based on ESHRE evidence-based guide-
lines (exclusion of APS in women, karyotyping of both partners for exclusion
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of chromosome abnormalities, ultrasonography and/or hysteroscopy
for exclusion of uterine anatomical abnormalities) (Jauniaux et al., 2006);
(iv) control group deﬁned as women with at least one live birth and no preg-
nancy complications (no SAmandatory); (v) genotyping ofNOS3 gene varia-
tions performed by ASO-PCR, PCR-RFLP or sequencing; (vi) genotype
frequencies reported; (vii) no deviation of genotype frequencies from
Hardy–Weinberg equilibrium (HWE) in the control group.
Data extraction
For each study included in the systematic review, and afterwards in
meta-analyses, the following data were extracted: authors, year of publica-
tion, ethnicity and number of patients and controls, IRSA deﬁnition, diagnos-
tic evaluations performed in IRSAwomen, inclusion and/orexclusion criteria
for controls, NOS3 gene variations analyzed, methods used for genotyping,
genotypes and allele frequencies. Additionally, we calculatedHWE for geno-
type frequencies of VNTR in intron 4 and +894 G/T SNP in patient and
control groups for each study.
Statistical analysis
Genetic association study
All statistical analyseswere carriedoutusing Statistica forWindows, version 10
(StatSoft, Inc., Tulsa, OK, USA) and MedCalc for Windows, version 13.3.3
(MedCalc Software, Mariakerke, Belgium), with the exception of statistical
power, which was calculated using DSS Researcher’s Toolkit (www.
dssresearch.com/toolkit/spcalc/power_p2.asp), as well as deviations from
HWE, which were tested using the Simple Hardy–Weinberg Calculator –
Court Lab (Washington State University College of Veterinary Medicine,
Pullman, WA, USA). Differences in genotype and allele frequencies between
patients and controls were tested using Pearson’s chi square (X2) test. The
associations of the two variations with the risk of IRSA were estimated by
odds ratios (OR) and their 95% conﬁdence intervals (CI). P-values ,0.05
were considered statistically signiﬁcant.
Meta-analyses
Meta-analyses were performed using Comprehensive Meta-Analysis,
version 2.2.064 (Biostat, Inc., Englewood, NJ, USA). For each study, individ-
ual and summary ORs and associated 95%CI were calculated under domin-
ant and recessive models, using ﬁxed and random effects model. Tests for
heterogeneity were performed for each meta-analysis using Cochran’s Q
test. Sensitivity analysis was performed by removing one study at a time to
evaluate the relative inﬂuence of each study on the pooled estimate. Publica-
tion bias was tested using the funnel plot and Egger’s regression test. A
P-value ,0.05 was considered signiﬁcant for all analyses. All P-values were
two-tailed.
Results
Genetic association study
The power of the present study was 80% to detect a 2-fold increase in
VNTR A allele frequency and 90% to detect a 1.5-fold increase in
+894 T allele. The distributions of VNTR in intron 4 and +894 G/T
SNP genotypes in IRSA and control women were in HWE (discussed
below). Genotypes and alleles frequencies of VNTR in intron 4 and
+894 G/T SNP in IRSA and control women are presented in Table I,
whereas the association with IRSA under different genetic models is
shown in Table II. There were no statistically signiﬁcant differences in
the distribution of genotypes and alleles frequencies between IRSA
and control women or association with IRSA under any genetic model.
Additionally, genotypes and alleles frequencies were similar between
women with primary and secondary IRSA, and we found no association
of either variation with primary and secondary IRSA under any genetic
model (data not shown).
........................................................................................
Table I Genotype and allele frequencies of theNOS3
VNTRin intron4and1894G/TSNPinwomenwith IRSA
and control women.
NOS3 IRSA
women
N (%)
Control
women
N (%)
X2 P-value
VNTR in intron 4
Genotype
BB 118 (79.7) 121 (81.2) 0.20 0.906
AB 26 (17.6) 25 (16.8)
AA 4 (2.7) 3 (2.0)
Allele
B 262 (88.5) 267 (89.6) 0.18 0.672
A 34 (11.5) 31 (10.4)
+894 G/T SNP
Genotype
GG 74 (50.0) 65 (43.6) 1.62 0.444
GT 54 (36.5) 65 (43.6)
TT 20 (13.5) 19 (12.8)
Allele
G 202 (68.2) 195 (65.4) 0.53 0.467
T 94 (31.8) 103 (34.6)
................................
........................................................................................
Table II Association of NOS3 VNTR in intron 4 and
1894 G/T SNP with IRSA under different genetic
models.
NOS3 genetic model IRSA versus control
women
OR (95% CI) P
VNTR in intron 4
Dominant: AA + AB versus BB 1.10 (0.62–1.95) 0.748
Recessive: AA versus AB + BB 1.35 (0.30–6.15) 0.696
Co-dominant: AA versus BB 1.37 (0.30–6.24) 0.686
AA versus AB 1.28 (0.26–6.31) 0.760
BB versus AB 0.94 (0.51–1.72) 0.835
Alleles: A versus B 1.12 (0.67–1.87) 0.672
+894 G/T
Dominant: TT + GT versus GG 0.77 (0.49–1.22) 0.271
Recessive: TT versus GT + GG 1.07 (0.54–2.10) 0.846
Co-dominant: TT versus GG 0.92 (0.45–1.88) 0.829
TT versus GT 1.27 (0.61–2.61) 0.522
GG versus GT 1.37 (0.84–2.24) 0.209
Alleles: T versus G 0.88 (0.63–1.24) 0.467
CI, conﬁdence interval; OR, odds ratio.
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Systematic review
The ﬂow diagram showing the details for the study searching is shown in
Fig. 1. We identiﬁed 16 case–control studies on the association between
NOS3 gene variations and IRSA, which we meticulously evaluated accord-
ing to several criteria (Table III).Twoadditional studieswere inChineseand
wereexcluded fromthe review (Fanet al., 2007;Gaoet al., 2009). Thirteen
studies analyzed the VNTR in intron 4 (Table IV), 11 studies analyzed the
+894G/T SNP (TableV), 7 studies analyzed the -786 T/CSNP, 2 studies
analyzed rs1007311, and 11 variations were each analyzed once in 3
studies. Molecular analysis was appropriate in all studies.
In the next stepwe divided the 16 studies into two groups based on the
deﬁnition of IRSA: the ﬁrst one comprised studies deﬁning IRSA as two or
more SAs (Table IIIA), and the second as at least three SAs. The latterwas
furtherdivided intotwosubgroupsaccording tomandatorydiagnosticeva-
luations performed in IRSA women and deﬁnition of the control group:
one that contained studies with certain limitations and the other one
that contained studies in which proper diagnostic evaluations were
performed and were included in meta-analyses (Table IIIB and C).
Idiopathic RSA was deﬁned as two or more SAs in three studies
(Table IIIA). The mandatory diagnostic evaluations in IRSA women were
appropriately performed, but the selection criteria for the control group
in the study by Makino et al. (2004) are arguable because according to
their data 65.8% of women were never pregnant.
In the remaining 13 studies and the present study, IRSAwas deﬁned as
threeormoreSAs. Seven studieshad limitations (Table IIIB),whereas the
other six had appropriate diagnostic evaluations performed in IRSA
women, as well as adequately deﬁned control groups (Table IIIC).
Regarding the seven studies with limitations, three of them had no
patient criteria inclusion and exclusion described (Al Sallout and Sharif,
2010; Shin et al., 2010; El-Gharably and Sharif, 2013), while in two
other studies APS was not excluded in IRSA women (Karvela et al.,
2008; Zammiti et al., 2008). In the study by Oztu¨rk et al. (2011) the
number of SA as a criteria for IRSA deﬁnition was not described in the
section Subjects, although IRSA was deﬁned as three or more SAs in
the Introduction. Furthermore, the control group inclusion andexclusion
criteria were not appropriately deﬁned in three studies (Zammiti et al.,
2008; Oztu¨rk et al., 2011; Abulata et al., 2014). In addition, in the
Figure1 PRISMAﬂowdiagramdetailing the inclusion andexclusion criteria, and thenumberof studies includedandexcludedateachstepof the literature
search.
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Table III Characteristics of studies on the association betweenNOS3 gene variations and IRSA.
Authors Ethnicity
of women
IRSAwomen Control women NOS3 gene variation tested
N IRSA
deﬁnition
Primary or
secondary
IRSA
Ultrasonography/
hysteroscopy
Karyotyping
of both
partners
APS Other exclusion
criteria
N Live
births
No pregnancy
complicationsa
VNTR in
intron 4
1894
G/T
SNP
Other
(A) Two or more:
Buchholz et al.
(2004)
German 179 Consecutive
SA before 25th
week of
gestation
ND + + + † abnormal thyroid
function
† polycystic ovary
syndrome
† deﬁciencies of
antithrombin, protein
C and S
126 1 + +
Makino et al.
(2004)
Japanese 85 SA before 10th
week of
gestation
ND + + + † abnormal
immunologic tests for
natural killer cell
activity
† abnormal thyroid
function
† diabetes mellitus
† hyperprolactinemia
† infections
76 26 with live
births
50 without
live births
+ +
Dutra et al.
(2014)
Brazilians 145 Consecutive
SA before 24th
week of
gestation with
the same
partner
Primary + + + † abnormal hormonal
status
135 2 + + -786 T/C
SNP
(B) Three or
more:
Al Sallout and
Sharif (2010)
Palestinians 99 Consecutive
SA before 25th
week of
gestation
ND NDb † infections 99 1 + +
Karvela et al.
(2008)
Greeks 126 SA before 20th
week of
gestation with
the same
partner
ND + + ND † ND 130 2 + + +
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Zammiti et al.
(2008)
Tunisians 350 Consecutive
SA before 30th
week of
gestation
ND + + ND † infections
† diabetes mellitus
† abnormal thyroid
function
† hyperprolactinemia
† erythroblastosis
fetalis-Rh disease
† immune
thrombocytopenic
purpura
† foeto-maternal
alloimmune
thrombocytopenia
200 NDc + + + -786 T/C
SNP
Shin et al.
(2010)
Koreans 340 Consecutive
SA
ND NDb † ND 115 1 + + + -786 T/C
SNP
Oztu¨rk et al.
(2011)
Turkish 60d NDe ND + + + † abnormal thyroid
function
† diabetes mellitus
† inﬂammatory diseases
60f NDg + + +
El-Gharably
and Sharif
(2013)
Palestinians 45 SA before 20th
week of
gestation
ND NDb † ND 45 2 + + + -786 T/C
SNP
Abulata et al.
(2014)
Egyptians 50 SA before 20th
week of
gestation with
the same
partner
ND + + + † infections
† abnormal hormonal
status
50 ND + + -786 T/C
SNP
(C) Three or
more:
Tempfer et al.
(2001)
Austrians 105 Consecutive
SA before 20th
week of
gestation with
the same
partner
NDh + + + † infections
† abnormal hormonal
status
91 2 + +
Heﬂer et al.
(2002)
130 67 +
Suryanarayana
et al. (2006)
South
Indians
145 First trimester
SA
Primary + + + † infections 99 1 + + + rs1007311
Parveen et al.
(2011)
North
Indians
200 SA Primary + + + † abnormal hormonal
status
† prothrombotic risk
factors (activated
protein-C resistance,
factor V Leiden and
prothrombin
mutations)
† luteal-phase
insufﬁciency
† diabetes mellitus
† abnormal thyroid
function
† infections
300 2 + + + rs1007311
rs79468462
rs9282804
rs617606555
Continued
N
O
S3
G
ene
variations
in
recurrentspontaneous
abortion
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Table III Continued
Authors Ethnicity
of women
IRSAwomen Control women NOS3 gene variation tested
N IRSA
deﬁnition
Primary or
secondary
IRSA
Ultrasonography/
hysteroscopy
Karyotyping
of both
partners
APS Other exclusion
criteria
N Live
births
No pregnancy
complicationsa
VNTR in
intron 4
1894
G/T
SNP
Other
Almawi et al.
(2013)
Bahrain
Arabs
296 SA during the
ﬁrst trimester
of gestation
with the same
partner
Primary: 217
(73.3%)
secondary:
79 (26.7%)
+ + i + j † Rh blood group
incompatibility
† systemic autoimmune
disease
† diabetes mellitus
† abnormal thyroid
function
† infections
† abnormal liver
function
305 2 + + + -786 T/C
SNP
rs3918188
rs743507
Luo et al.
(2013)
Chinese 340k Consecutive
SA
ND + + + † endocrine disorder
† autoimmune disorder
† infections
115l 1 + + -786 T/C
SNP
rs11771443
rs1541861
rs3918188
rs2853792
rs2853796
rs7830
Present study Slovenians 148 Consecutive
SA before
22nd week of
gestation with
the same
partner
Primary: 97
(65.5%)
secondary:
51 (34.5%)
+ + + † abnormal hormonal
status
† infections
149 2 + + +
(A) Studies deﬁning IRSA as two or more SA; (B) studies deﬁning IRSA as three or more SA, but with certain limitations; (C) studies deﬁning IRSA as three or more SA, included in meta-analysis.
APS, antiphospholipid syndrome; ND, not described; SA, spontaneous abortion.
aIncluding SA.
bInclusion and exclusion criteria not described.
cOnly the mean number of children is mentioned in the paper.
dGenotype data for VNTR in intron 4 available for 54, not 60 patients as indicated in the paper.
eThe number of SAs is not deﬁned in the section Subjects, although IRSA is deﬁned as three or more SAs in the Introduction.
fGenotype data for VNTR in intron 4 available for 70, not 60 controls as indicated in the paper.
gAuthors indicate that the control group consisted of multipara women, but did not specify the number of live births.
hAuthors deﬁne primary IRSA as no history of a pregnancy carried beyond 20 weeks of gestation and secondary IRSA as a history of at least one pregnancy carried beyond 20 weeks of gestation.
iPerformed in 38.9% of the initial number of patients.
jPerformed in 67.6% of the initial number of patients.
kGenotype data for +894 G/T SNP available for 192, not 340 patients as indicated in the paper.
lGenotype data available for 201, not 115 controls as indicated in the paper.
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study by Oztu¨rk et al. (2011), genotype frequencies signiﬁcantly deviate
fromHWE in the control group, and are opposite to all other studies, in-
dicating a possible genotyping error (Table IV). Finally, differences in the
number of patients and controls reported in text and tables were
detected in two studies (Table III; Oztu¨rk et al., 2011; Luo et al., 2013).
Meta-analysis of VNTR in intron 4
Five studies, including the present study, met the criteria for inclusion in
the meta-analysis of VNTR in intron 4 (Table IIIC and Fig. 1) (Tempfer
et al., 2001; Suryanarayana et al., 2006; Parveen et al., 2011; Almawi
et al., 2013). These ﬁve studies included 894 patients and 944 controls.
The association between VNTR in intron 4 and IRSAwas not statistically
signiﬁcant under the dominant (AA + AB versus BB) nor recessive
genetic model (AA versus AB + BB), based on both ﬁxed and random
effects models (Fig. 2). There was no evidence of among-study hetero-
geneity (Cochran’s Q test:X2 ¼ 4.73; df ¼ 4; P ¼ 0.316; Higgins statis-
tics: I2 ¼ 15.47%) or publication bias (t ¼ 1.51; df ¼ 3.00; P ¼ 0.227)
under the dominant genetic model. However, the among-study hetero-
geneity was statistically signiﬁcant under the recessive genetic model
(Cochran’s Q test: X2 ¼ 12.58; df ¼ 4; P ¼ 0.013; Higgins statistics:
I2 ¼ 68.2%), whereas no publication bias was detected (t ¼ 0.08;
df ¼ 3.00; P ¼ 0.939).
Meta-analysis of 1894 G/T SNP
Six studies, including the present study, met the criteria for inclusion in
the meta-analysis of +894 G/T SNP, with a total of 1111 patients and
1121 controls (Table IIIC and Fig. 1) (Heﬂer et al., 2002; Suryanarayana
et al., 2006; Parveen et al., 2011; Almawi et al., 2013; Luo et al., 2013).
The association between +894 G/T SNP and IRSAwas statistically sig-
niﬁcant under the dominant genetic model (GT + TT versus GG) based
on both ﬁxed and random effects models (Fig. 3). The among-study het-
erogeneity was statistically signiﬁcant (Cochran’s Q test: X2 ¼ 21.83;
df ¼ 5; P ¼ 0.001;Higgins statistics: I2 ¼ 77.1%),while therewasno evi-
dence of publication bias (t ¼ ,0.01; df ¼ 4.00; P ¼ 0.999). On the
contrary, there was no association between +894 G/T SNP and IRSA
under the recessive genetic model (TT versus GT + GG) based on
both ﬁxed and random effects models (Fig. 3). We detected no among-
study heterogeneity (Cochran’s Q test: X2 ¼ 8.9; df ¼ 5; P ¼ 0.111;
Higgins statistics: I2 ¼ 44.1%) or publication bias (t ¼ 0.15; df ¼ 4.00;
P ¼ 0.886).
Discussion
In this study, we tested the association of NOS3 VNTR in intron 4 and
+894 G/T SNPwith IRSA in Slovenian women, conducted a systematic
reviewof literature on the role ofNOS3 gene variations in IRSA, and per-
formed meta-analyses of VNTR in intron 4 and +894 G/T SNP. The
meta-analyses demonstrated that the VNTR in intron 4 in women
does not contribute to IRSA, whereas the variant (T) allele of the
+894 G/T SNP is associated with IRSA when considered under the
dominant genetic model.
..................................................................................................................................................
...................................................................... ......................................................................
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Table IV Genotype frequencies obtained in studies on the association betweenNOS3 VNTR in intron 4 and IRSA.
Authors VNTR in intron 4 genotype frequency/N (%)
IRSAwomen Control women
BB AB AA Total HWE BB AB AA Total HWE
(A)
Buchholz et al. (2004) 123 (68.7) 52 (29.1) 4 (2.2) 179 0.582 82 (65.1) 39 (30.9) 5 (4.0) 126 0.893
Makino et al. (2004) 70 (82.4) 15 (17.6) 0 (0) 85 0.372 62 (81.6) 14 (18.4) 0 (0) 76 0.376
(B)
Al Sallout and Sharif (2010) 65 (65.0) 30 (30.0) 4 (4.0) 99 0.819 67 (67.7) 32 (32.3) 0 (0) 99 0.055
Karvela et al. (2008) 95 (75.4) 30 (23.8) 1 (0.8) 126 0.407 95 (73.1) 31 (23.8) 4 (3.1) 130 0.460
Zammiti et al. (2008) 231 (66.0) 97 (27.7) 22 (6.3) 350 0.009 146 (73.0) 46 (23.0) 8 (4.0) 200 0.084
Shin et al. (2010) 275 (80.9) 63 (18.5) 2 (0.6) 340 0.427 90 (78.2) 24 (20.9) 1 (0.9) 115 0.662
Oztu¨rk et al. (2011) 0 (0) 16 (29.6) 38 (70.4) 54 0.201 6 (8.6) 10 (14.3) 54 (77.1) 70 ,0.001
El-Gharably and Sharif (2013) 43 (95.6) 2 (4.4) 0 (0) 45 0.879 45 (100) 0 (0) 0 (0) 45 0.881
Abulata et al. (2014) 22 (44.0) 19 (38.0) 9 (18.0) 50 0.191 40 (80.0) 10 (20.0) 0 (0) 50 0.432
(C)
Tempfer et al. (2001) 65 (61.9) 39 (37.1) 1 (0.9) 105 0.190 69 (75.8) 22 (24.2) 0 (0) 91 0.190
Suryanarayana et al. (2006) 101 (69.7) 43 (29.6) 1 (0.7) 145 0.114 71 (71.7) 28 (28.3) 0 (0) 99 0.101
Parveen et al. (2011) 133 (66.5) 50 (25.0) 17 (8.5) 200 ,0.001 214 (71.3) 74 (24.7) 12 (4.0) 300 0.091
Almawi et al. (2013) 177 (59.8) 114 (38.5) 5 (1.7) 296 0.005 176 (57.7) 109 (35.7) 20 (6.6) 305 0.576
Present study 118 (79.7) 26 (17.6) 4 (2.7) 148 0.098 121 (81.2) 25 (16.8) 3 (2.0) 149 0.223
(A) Studies deﬁning IRSA as two or more SA; (B) studies deﬁning IRSA as three or more SA, but with certain limitations; (C) studies deﬁning IRSA as three or more SA, included in
meta-analysis.
HWE, Hardy–Weinberg equilibrium.
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Characteristics of studies on the association
ofNOS3 gene variations with IRSA
Atotal of 16 studieswerepublishedon the associationbetween15NOS3
gene variations and IRSA. Only a minority of studies comply with the
evidence-based guidelines, whereas most show inconsistencies in
design, primarily in patients and controls selection criteria. The ﬁrst
major disparity we observed concerns the deﬁnition of IRSA, especially
regarding the minimum number of SAs needed for diagnosis. IRSA was
deﬁned as two ormore SAs in three studies, although no available guide-
line recommends scientiﬁc research under this criterion (American
College of Obstetricians and Gynecologists, 2002; Christiansen et al.,
2005; Laurino et al., 2005; Porter and Scott, 2005; Jauniaux et al.,
2006; Practice Cmmittee of the American Society for Reproductive
Medicine, 2012). Furthermore, all 16 studies differed considerably in
reporting the order of SAs, upper limit of gestational age required for
the diagnosis of SA, classiﬁcation of couples into primary and secondary
aborters, and the information on whether the SAs were with the same
partner. The second major objection regards the abundance of unwar-
ranted diagnostic evaluations performed in IRSA women regardless of
clinical indications or evidence provided in the scientiﬁc literature, even
when the basic clinical evaluation was not performed. In addition,
three studies had no patient inclusion and exclusion criteria described
(Al Sallout and Sharif, 2010; Shin et al., 2010; El-Gharably and Sharif,
2013). Finally, the selection of women for the control group differed to
a great extent between studies. Considering that no universal criteria
for controls exist (Rull et al., 2012), we set the minimum criteria as at
least one live birth and no pregnancy complications, including SA.
The role ofNOS3 gene variations in IRSA
Among the 15NOS3 gene variations tested in IRSAwomen, theVNTR in
intron 4, +894 G/T SNP and -786 T/C SNP were investigated in more
than two studies. The remaining 11 variations were tested once and 1
was tested twice, precluding us frommaking conclusions on their associ-
ation with IRSA. The -786 T/C SNP (rs2070744) was investigated in
seven studies, but meta-analysis was not performed because only two
studies met the inclusion criteria.
The VNTR in intron 4 consists of ﬁve (wild-type B allele) or four
(mutant A allele) copies of a 27-bp repeat. The VNTR was shown to
act as an enhancer/repressor regulating NOS3 expression, and the
27-bp repeats are the source of a 27-nt small RNA, a short intronic
repeat small RNA, which functions as a negative feedback regulator
and maintains the stable expression of NOS3 (Wang et al., 2002;
Zhang et al., 2008). The mutant (A) allele produces lower levels of the
27-nt small RNA, leading to higher NOS3 expression. However, the as-
sociation with changes in plasma NO, nitrite and nitrate concentrations
remains inconclusive (Tsukada et al., 1998; Salimi et al., 2008). Our
genetic association study and meta-analysis indicate that the VNTR in
intron 4 does not contribute to IRSA.
The+894G/T SNP is locatedwithin theNOS3open reading frame at
exon 7 (Wattanapitayakul et al., 2001). This missense SNP corresponds
to a substitution of glutamate to aspartate at amino acid position 298.
Various reports associated this SNP with altered functional properties
of eNOS and basal levels of NO (Wattanapitayakul et al., 2001;
Veldman et al., 2002). It was also shown that the presence of the T
allele does not affect NOS3 steady state transcription in endothelial
..................................................................................................................................................
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Table V Genotype frequencies obtained in studies on the association betweenNOS3 1894 G/T SNP and IRSA.
Authors NOS3 1894 G/T SNP genotype frequency/N (%)
IRSAwomen Control women
GG GT TT Total HWE GG GT TT Total HWE
(A)
Dutra et al. (2014) 84 (58.0) 53 (36.5) 8 (5.5) 145 0.924 69 (51.1) 57 (42.2) 9 (6.7) 135 0.397
(B)
Karvela et al. (2008) 53 (42.1) 57 (45.2) 16 (12.7) 126 0.912 62 (47.7) 58 (44.6) 10 (7.7) 130 0.478
Zammiti et al. (2008) 256 (73.1) 83 (23.7) 11 (3.2) 350 0.190 157 (78.5) 39 (19.5) 4 (2.0) 200 0.398
Shin et al. (2010) 266 (78.2) 60 (17.7) 14 (4.1) 340 ,0.001 103 (89.6) 12 (10.4) 0 (0) 115 0.555
Oztu¨rk et al. (2011) 42 (70.0) 18 (30.0)a 60 NA 28 (46.7) 32 (53.3)a 60 NA
El-Gharably and Sharif (2013) 26 (57.8) 19 (42.2)a 45 NA 22 (48.9) 23 (51.1)a 45 NA
(C)
Heﬂer et al. (2002) 60 (46.2) 57 (43.8) 13 (10.0) 130 0.920 32 (47.8) 27 (40.3) 8 (11.9) 67 0.537
Suryanarayana et al. (2006) 91 (62.8) 47 (32.4) 7 (4.8) 145 0.770 69 (69.7) 27 (27.3) 3 (3.0) 99 0.856
Parveen et al. (2011) 155 (77.5) 42 (21.0) 3 (1.5) 200 0.936 278 (92.7) 22 (7.3) 0 (0) 300 0.510
Almawi et al. (2013) 154 (52.1) 109 (36.8) 33 (11.1) 296 0.046 194 (63.6) 95 (31.1) 16 (5.3) 305 0.334
Luo et al. (2013) 118 (61.5) 72 (37.5) 2 (1.0) 192 0.012 154 (76.6) 41 (20.4) 6 (3.0) 201 0.122
Present study 74 (50.0) 54 (36.5) 20 (13.5) 148 0.054 65 (43.6) 65 (43.6) 19 (12.8) 149 0.664
(A) Studies deﬁning IRSA as two or more SA; (B) studies deﬁning IRSA as three or more SA, but with certain limitations; (C) studies deﬁning IRSA as three or more SA, included in
meta-analysis.
NA, not applicable.
aFrequencies for GT and TT genotypes were not shown separately.
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cells, but rather affects the function of eNOS under shear stress (Joshi
et al., 2007). The T allele leads to decreased eNOS activity and altera-
tions in localization at the endothelial caveolae, reducing the response
to shear stress, impairing enzyme regulation and NO bioavailability
(Joshi et al., 2007). In addition, the T allele generates protein products
with differing susceptibility to cleavage (Tesauro et al., 2000). In the
present study,we foundnoassociationbetween theSNPand IRSA in Slo-
venian women. However, the results of meta-analysis show thatwomen
homozygous and heterozygous for the variant (T) allele have a 1.5-fold
increased risk of IRSA compared with women homozygous for the G
allele. The discrepancy between the results of our case–control study
and meta-analysis regarding the +894 G/T SNP might be the conse-
quence of population differences and/or the number of participants
included in case–control studies. Signiﬁcant associations between this
SNP and IRSA were determined in North Indian, Bahrain Arab and
Chinese women, whereas the association was not conﬁrmed in Euro-
pean Caucasians (Slovenians and Austrians) and South Indians. In add-
ition, the three studies with positive associations had the largest
number of participants.
The pathophysiologic signiﬁcance of VNTR in intron 4 and+894G/T
SNP in IRSA has not been well investigated. Only two studies evaluated
the impact of these variations on plasma NO levels in IRSAwomen and
found no association (Oztu¨rk et al., 2011; El-Gharably and Sharif, 2013).
However, both studies had major limitations (Table III). In the study by
Oztu¨rk et al. (2011) the control group was not well deﬁned, and geno-
type frequencies signiﬁcantly deviated from HWE and were opposite
to all other studies, indicating a possible genotyping error, whereas the
study by El-Gharably and Sharif (2013) had no patient inclusion and
exclusion criteria described. Therefore, future studies should focus on
the evaluation of the functional signiﬁcance of +894 G/T SNP in IRSA
women, regarding alterations in eNOS mRNA and protein levels and
activity, as well as NO, nitrites and nitrate concentrations in plasma
and endometrium.
Comparison to previous meta-analyses
In all three meta-analysis, the association with IRSA was signiﬁcant only
for the +894 G/T SNP under the dominant genetic model. However,
the summary OR was higher in our meta-analysis (ORrandom ¼ 1.54,
95% CI ¼ 1.03–2.31, P ¼ 0.033) than in the paper by Su et al. (2011).
Comparison with the results presented by Cao et al. (2014) is discussed
below. Regardless of similar results, previousmeta-analyses have several
shortcomings regarding their design.
First, in both of the previousmeta-analyses the inclusion and exclusion
criteria for study selectionwere not based on any guideline for the evalu-
ation of IRSA and the condition was deﬁned as two or more SAs. In the
meta-analyses by Su et al. (2011) the criteria for proven causes of RSA
were not chosen appropriately and the process of study selection was
Figure 2 Association of VNTR in intron 4 and IRSA under dominant (A) and recessive (B) genetic models. Results of individual and summary OR esti-
mates with 95% CIs of each study are shown. Horizontal lines represent 95% CIs and vertical lines the value of the summary OR.
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not conducted in accordance with those criteria. The inclusion criteria
for IRSA patients in the meta-analysis by Cao et al. (2014) are not
detailed. In both papers, meta-analyses were performed for all case–
control studies that were published up to a selected date.
Second, the quality of included studies was assessed using three (Cao
et al., 2014) or ﬁve (Su et al., 2011) criteria, additionally graded as ad-
equate, inadequate, not described or not stated. However, we noticed
a contradiction in grading between criteria. For example, both papers
state that the studies by Al Sallout and Sharif (2010) and Shin et al.
(2010) had adequately described patients, but that patient selection
criteria were not described in either study.
Third, the calculationofHWE isoneof themajor quality control checks
in meta-analyses of genetic association studies. A deviation in the control
group may bias the estimates of effects and the study should be excluded
(Munafo` and Flint, 2004). Unlike previous meta-analyses, we calculated
HWE for all studies and excluded one study (Oztu¨rk et al., 2011) from
further analysis.
Fourth, the reliability of the meta-analysis performed by Cao et al.
(2014) is arguable for severalother reasons. The total numberof subjects
included inmeta-analysespresented in tables, results andabstract aredif-
ferent, and data for the study by Gao et al. (2009) differed from the
original paper. The study by Oztu¨rk et al. (2011) was not included in
the meta-analysis of the +894 G/T SNP. Furthermore, the ﬂowchart
is unelaborated, not all studies included in meta-analyses were cited,
and the case–control study by Gao et al. (2009) is cited as the source
for the selection criteria.
Finally, we re-calculated the summaryORs for both gene variations in
both meta-analyses. While we obtained identical results to those of
Su et al. (2011), our observations differed from those of Cao et al.
(2014). These discrepancies could be due to differences in statistical pro-
grams; however, this is unlikely given thatComprehensiveMeta-Analysis
andMIX software, used byCao et al. (2014), provide identical numerical
results (Bax et al., 2007).
Limitations and strengths of the present study
One of the limitations of this meta-analysis is the among-study hetero-
geneity that was detected for the +894 G/T SNP under the dominant
genetic model. Although it was not possible to recognize the source of
heterogeneity considering the strict inclusion criteria, it may be the con-
sequence of deviations fromHWE in the group of patients in the studies
by Almawi et al. (2013) and Luo et al. (2013), or population differences.
Figure3 Associationof+894G/Tsingle nucleotidepolymorphismand IRSAunder dominant (A) and recessive (B) geneticmodels. Resultsof individual
and summary ORs estimates with 95% CIs of each study are shown. Horizontal lines represent 95% CIs and vertical lines the value of the summary OR.
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Additionally, given the small number of studies included in this
meta-analysis, subgroup analysis by ethnicity was not performed.
Nevertheless, this study has several strengths. We tested the associ-
ation of VNTR in intron 4 and +894 G/T SNP with IRSA in Slovenian
women, therebybroadening the knowledgeon the role ofNOS3 gene var-
iations in an additional population. Also, the search for studies on the as-
sociationbetweenNOS3genevariationsand IRSAwascomprehensiveand
systematic. Attemptsweremade to avoid limitations in the original papers
by applying strict criteria for study selection, which were based on ESHRE
evidence-based guidelines. In this way, we increased the homogeneity of
the study population, minimizing the possibility of selection bias.
Conclusions
The evidence presented in this paper indicates that the NOS3 VNTR in
intron 4 is not associated with IRSA, whereas the GT and TT genotypes
of the+894G/T SNPmight be factors of predisposition to IRSA. Similar
to the increasing number of critical reviews on IRSA, we detected signiﬁ-
cant differences in the inclusion and exclusion criteria for patients and
controls between studies (Rull et al., 2012; van den Boogard et al.,
2013; Christiansen, 2014). Additional genetic association studies in
different populations, larger number of participants and a uniformly
deﬁned IRSA are needed to clarify the contribution of the NOS3 +894
G/T SNP to IRSA. Future studies should also focus on the functional
signiﬁcance of +894 G/T SNP in IRSA.
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